Released June 15th, 2021
Matthew Harrison, Jason Kelly - Moderna: The Software of Life
Jason Kelly is the CEO of Gingko Bioworks and Matthew Harrison is a biotech analyst at Morgan Stanley. We cover the history of programming cells, what differentiates Moderna from other biotech companies, and lessons for entrepreneurs and investors can takeaway from Moderna's story.
Public Equity
Business Building
Listen now on
You must be logged in to view this content. Don't have an account? Register here. (It's free)